Oral presentation schedule for November 4 (Fri), Day 2
    Kobe International Exhibition Hall No.2 Building Portopia Hotel Kobe International Conference Center Kobe International Exhibition Hall No.1 Building Kobe International Exhibition Hall No.2 Building  
    Hall (South) Conference Room 3A Portopia Hall Ohwada A Ohwada B Ohwada C Kairaku 1 Kairaku 2 Kairaku 3 Waraku Topaz Emerald Ikuta 501+502 Digital Poster Session & Commercial Exhibition Digital Poster Session & Commercial Exhibition  
    Room 1 Room 2 Room 3 Room 4 Room 5 Room 6 Room 7 Room 8 Room 9 Room 10 Room 11 Room 12 Room 13 Room 14 Room 15 Room 16  
8:00   8:00
45 No planned seminars

Breakfast
Seminar8

Century Medical,Inc.
Not too late, Starting colonic stenting! -Aiming stoma free-
No planned seminars

Breakfast
Seminar9

Hitachi, Ltd.
Cutting edge of endoscopic biliary drainage

Breakfast
Seminar10

NIPPONKAYAKU CO., LTD.
Treatment strategy of IBD using biologics –Clinical experience with infliximab biosimilar–

Breakfast
Seminar11

GADELIUS MEDICAL K.K.
Plastic stent innovation part3

Breakfast
Seminar12

Kyorin Pharmaceutical Company, Limited
An update on the mode of action of 5-ASA in ulcerative colitis

Breakfast
Seminar13

Otsuka Pharmaceutical Co., Ltd. / Takeda Pharmaceutical Company Limited
Light and shadow in antithrombotic therapy

Breakfast
Seminar14

Yakult Honsha Co., Ltd.
The front-line of gastric cancer chemotherapy for surgeons

Breakfast
Seminar15

MIYARISAN PHARMACEUTICAL CO., LTD.
Application of intestinal microbiota for development of novel treatment

Breakfast
Seminar16

Eisai Co., Ltd. / EIDIA Co., Ltd
Update of HCC treatment

Breakfast
Seminar17

Alfresa pharma corporation
Novel strategy for IBD treatment using fecal biomarkes

Breakfast
Seminar18

EA Pharma Co., Ltd.
BCAA & Exercise Therapy for Hepatoma Patients
      45
9:00                           9:00
30

S2 (JSGS)
Laparoscopic gastrectomy <Video>

Chair: K. Yoshida
E. Otsuji

S3 (JSGS / JSGE / JGES)
Treatment strategy for rectal cancer

Chair: M. Watanabe
K. Maeda

PD8 (JSGE / JGES / JSGS)
Therapeutic strategy for biologics-resistant inflammatory bowel disease

Chair: A. Andoh
R. Hokari

W10 (JSGE / JGES / JSGS / JSGCS)
Issues and solutions in the management of pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm of the pancreas

Chair: M. Kon
K. Shimizu

Integrated Program 3(S) (JDDW (JSGE / JGES / JSGS))
Clinical issues in cancer of the esophagogastric junction

Chair: M. Ichinose
Y. Doki
T. Oyama

Invited Lecture (JSH)
Treatment strategy for hepatocellular carcinoma and future perspective

V. Mazzaferro
Chair: T. Takayama

W11 (JGES / JSGE / JSGS / JSGCS)
Cutting edge of endoscopic diagnosis and treatment for superficial cancer in hypopharynx and cervical esophagus

Chair: T. Omori
M. Arima

IS-S2 (JSGE / JSH)
Roles of microbiota for nervous, metabolic, and immune systems

Chair: M. E. Gershwin
T. Kanai

W13 (JSGS / JSGE)
New surgical approaches for advanced biliary cancer

Chair: M. Nagino
I. Endo

W14 (JSGS / JSGE / JSH)
3D simulation of the anatomy in the gastrointestinal and hepato-biliary pancreatic surgery

Chair: S. Kawasaki
K. Yanaga

W15 (JSH / JSGE)
Best treatment strategy for portal hypertension

Chair: S. Kokubu
A. Nakajima
Live broadcast
Room
Live broadcast
Room

JDDW 2016 Hands-on seminar 1 (ESD)

Coordinator:
Y. Morita
    Commercial Exhibition     Commercial Exhibition 30
40
Digital Poster Session (JSGS)
9:30
|
11:30
Digital Poster Session (JSGS)
9:30
|
11:30
International Poster Session
9:30
|
11:30
40
10:00

PD10 (JSH / JSGE / JSGS)
Best timing and limitation of surgical treatment for HCC

Chair: N. Kokudo
M. Shimada
10:00
11:00     11:00
20     20
30

Special Lecture (JSGE)
How to train young gastroenterologists with broad knowledge of internal medicine

T. Chiba
Chair: K. Sugano

Invited Lecture (JGES)
Update therapeutic approach to the upper GI diseases - focus on GERD

P. Malfertheiner
Chair: M. Kaise
30
12:00       12:00
30                                 30
13:00

Luncheon
Seminar40

MSD K.K.
New Treatment Option For Chronic Hepatitis C -Current Issue and Recent Evidence-

Luncheon
Seminar41

ONO PHARMACEUTICAL CO., LTD. / Bristol-Myers Squibb K.K.
Recent advances and future perspective of cancer immunotherapy
No planned seminars

Luncheon
Seminar42

JIMRO Co., Ltd.
Tips of GMA Therapy in Ulcerative Colitis

Luncheon
Seminar43

ZEON MEDICAL INC.
History and Progress of the Biliary and Pancreatic Endoscopic Treatment

Luncheon
Seminar44

Otsuka Pharmaceutical Co., Ltd.
Managements of Symptoms in Liver Cirrhosis
- Sarcopenia and Hepatic Encephalopathy - & OTSUKA Award 2016

Luncheon
Seminar45

EA Pharma Co, Ltd.
Consideration of acid secretion inhibitor in Japan

Luncheon
Seminar46

SHIONOGI & CO., LTD.
Symptom management in patients with gastroenterological cancer

Luncheon
Seminar47

Eli Lilly Japan K.K.
Chemotherapy of gastrointestinal cancer

Luncheon
Seminar48

CHUGAI PHARMACEUTICAL CO., LTD
Current treatment strategy for metastatic colorectal cancer
Representative Conference (Japanese Society of Gastrointestinal Cancer Screening)
12:30-13:30

Luncheon
Seminar49

Takeda Pharmaceutical Company Limited Medical Affairs-Japan
Role of the adhesion molecule on the inflammatory bowel disease

Luncheon
Seminar50

Johnson & Johnson K. K. Medical Company
The Latest Laparoscopic Hepatectomy
13:00
30       30
40   40
14:00                         14:00
40

PD7 (JGES / JSGE / JSGS / JSGCS)
Benefits and harms of ESD in the era of its bloom

Chair: H. Yamamoto
H. Ono

W9 (JSH / JSGE / JSGS)
Update of hepatitis B treatment

Chair: E. Tanaka
H. Okamoto

Lecture by Congress President (JSGS)
Where there is a will, there is a way - Yes, We Can

W. Kimura
Chair: Y. Atomi

PD9 (JSGE / JGES / JSGS / JSGCS)
Long-term clinical course of Japanese patients with inflammatory bowel disease: What are current and optimal modalities for monitoring disease activity?

Chair: T. Matsumoto
H. Nakase

Integrated Program 4(S) (JDDW (JSGE / JSGS))
Problems and tasks in pancreatic cancer treatment

Chair: H. Yamaue
J. Furuse

Invited Lecture (JGES)
Education for GI endoscopists in Taiwan

H.-P. Wang
Chair: S. Ryozawa

W12 (JSH / JSGE / JSGS)
Best timing of targeting therapy for hepatocellular carcinoma

Chair: M. Kudo
M. Omata

IS-S3 (JSGS / JSGE)
Benefit and pitfall in laparoscopic surgery

Chair: H.-S. Han
H. Kaneko

S4 (JSGE / JSH)
Current state of regenerative medicine and stem cell research in digestive system

Chair: M. Watanabe
T. Takehara
Live broadcast
Room
Live broadcast
Room
Live broadcast
Room

Women's Committee of Japanese Gastroenterology Study Group (JDDW)
The art of patients support by taking advantage of women doctors
-Learning from experts in various medical fields-

Chair: H. Ishii
Y. Takahashi

JDDW 2016 Hands-on seminar 2 (Colon insertion method)

Coordinator:
T. Matsuda
Digital Poster Session (JSGE)
14:00
|
16:30
Digital Poster Session (JSGS)
14:00
|
16:30
Digital Poster Session (JGES)
14:00
|
16:30
Digital Poster Session (JSH)
14:00
|
16:30
International Poster Session
14:00
|
16:30
40
15:00

Special Lecture (JSGS)
The story of researches over the Nobel Prize

Y. Morioka
Chair: T. Muto

JGES Featured Session <Panel Discussion> (JGES)
Interventional EUS: Its indications and limitations

Chair: S. Ryozawa
N. Fujita
15:00
20 20
16:00

Invited Lecture (JSGS)
Pancreatology 2016: What is new?

J. Mossner
Chair: H. Nagai
16:00
30

Invited Lecture (JSGS)
Parenchyma-sparing, local duodenum-preserving pancreatic head resection for cystic neoplasms, neuroendocrine adenoma and low-risk periampullary cancer

H. G. Beger
Chair: M. Makuuchi
30
40       40
17:00   17:00
10                                 10
30 Japan Gastroenterological Endoscopy Society Awards Ceremony 30
18:00 Incorporated Association Council and Academic Council (Japan Gastroenterological Endoscopy Society)
17:30-18:45

Satellite
Symposium72

Bristol-Myers Squibb K.K.
Trajectory of Chronic Hepatitis B treatment

Satellite
Symposium73

OLYMPUS CORPORATION
A Decade of NBI -The history and expansion to the world-

Satellite
Symposium74

MOCHIDA PHARMACEUTICAL CO., LTD.
A new therapeutic strategy for ulcerative colitis
Setting up the JDDW Banquet Room

Satellite
Symposium75

Sumitomo Dainippon Pharma Co., Ltd
The Treatment of hepatocellular carcinoma using miriplatin

Satellite
Symposium76

EA Pharma Co., Ltd.
Strategy of improving the prognosis for patients with liver cirrhosis -Efficacy of early nutrition support by BCAA for liver cirrhosis-

Satellite
Symposium77

ASKA Pharmaceutical Co., Ltd.
Management for Hepatic cirrhosis

Satellite
Symposium78

Otsuka Pharmaceutical Factory,Inc. / EN Otsuka Pharmaceutical Co., Ltd.
Up to date on the Medical Management of Crohn's Disease

Satellite
Symposium79

Sysmex Corporation
Remaining Challenges for the Post-hepatitis-virus Era

Satellite
Symposium80

Covidien Japan Inc.
–KIWAMERU (Master) – Our laparoscopic colon resection

Satellite
Symposium81

TAIHO PHARMACEUTICAL CO., LTD.
Development in the treatment of advanced gastric cancer–laparoscopic surgery and adjuvant chemotherapy–

Satellite
Symposium82

MEDICO'S HIRATA INC.
VIVARF Seminar
18:00
30       30
45               45
50   50
19:00   19:00
30       Social Gathering (after the Satellite Seminar)                     30
20:00     20:00
                                   

Copyright © JDDW 2016. All Rights Reserved.